Literature DB >> 22001310

A conserved antioxidant response element (ARE) in the promoter of human carbonyl reductase 3 (CBR3) mediates induction by the master redox switch Nrf2.

Qiuying Cheng1, James L Kalabus, Jianping Zhang, Javier G Blanco.   

Abstract

Carbonyl reductase activity catalyzes the two electron reduction of several endogenous and exogenous carbonyl substrates. Recent data indicate that the expression of human carbonyl reductase 3 (CBR3) is regulated by the master redox switch Nrf2. Nrf2 binds to conserved antioxidant response elements (AREs) in the promoters of target genes. The presence of functional AREs in the CBR3 promoter has not yet been reported. In this study, experiments with reporter constructs showed that the prototypical Nrf2 activator tert-butyl hydroquinone (t-BHQ) induces CBR3 promoter activity in cultures of HepG2 (2.7-fold; p<0.05) and MCF-7 cells (22-fold; p<0.01). Computational searches identified a conserved ARE in the distal CBR3 promoter region ((-2698)ARE). Deletion of this ARE from a 4212-bp CBR3 promoter construct impacted basal promoter activity and induction of promoter activity in response to treatment with t-BHQ. Deletion of (-2698)ARE also impacted the induction of CBR3 promoter activity in cells overexpressing Nrf2. Electrophoretic mobility shift assays (EMSA) demonstrated increased binding of specific protein complexes to (-2698)ARE in nuclear extracts from t-BHQ treated cells. The presence of Nrf2 in the specific nuclear protein-(-2698)ARE complexes was evidenced in EMSA experiments with anti-Nrf2 antibodies. These data suggest that the distal (-2698)ARE mediates the induction of human CBR3 in response to prototypical activators of Nrf2.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001310      PMCID: PMC3225504          DOI: 10.1016/j.bcp.2011.09.027

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  36 in total

Review 1.  Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens.

Authors:  S Dhakshinamoorthy; D J Long; A K Jaiswal
Journal:  Curr Top Cell Regul       Date:  2000

Review 2.  Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems.

Authors:  S A Bustin
Journal:  J Mol Endocrinol       Date:  2002-08       Impact factor: 5.098

Review 3.  Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?

Authors:  Brian D Lawenda; Kara M Kelly; Elena J Ladas; Stephen M Sagar; Andrew Vickers; Jeffrey B Blumberg
Journal:  J Natl Cancer Inst       Date:  2008-05-27       Impact factor: 13.506

4.  Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.

Authors:  Javier G Blanco; Can-Lan Sun; Wendy Landier; Lu Chen; Diego Esparza-Duran; Wendy Leisenring; Allison Mays; Debra L Friedman; Jill P Ginsberg; Melissa M Hudson; Joseph P Neglia; Kevin C Oeffinger; A Kim Ritchey; Doojduen Villaluna; Mary V Relling; Smita Bhatia
Journal:  J Clin Oncol       Date:  2011-11-28       Impact factor: 44.544

5.  Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.

Authors:  G L Forrest; B Gonzalez; W Tseng; X Li; J Mann
Journal:  Cancer Res       Date:  2000-09-15       Impact factor: 12.701

Review 6.  Reactive carbonyls and oxidative stress: potential for therapeutic intervention.

Authors:  Elizabeth M Ellis
Journal:  Pharmacol Ther       Date:  2007-05-08       Impact factor: 12.310

Review 7.  Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors.

Authors:  Paul Nioi; John D Hayes
Journal:  Mutat Res       Date:  2004-11-02       Impact factor: 2.433

8.  Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol.

Authors:  R D Olson; P S Mushlin; D E Brenner; S Fleischer; B J Cusack; B K Chang; R J Boucek
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

9.  Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1.

Authors:  Lisa E Olson; Djahida Bedja; Sara J Alvey; A J Cardounel; Kathleen L Gabrielson; Roger H Reeves
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

Review 10.  Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity.

Authors:  Giorgio Minotti; Pierantonio Menna; Emanuela Salvatorelli; Gaetano Cairo; Luca Gianni
Journal:  Pharmacol Rev       Date:  2004-06       Impact factor: 25.468

View more
  5 in total

1.  Effects of JUN and NFE2L2 knockdown on oxidative status and NFE2L2/AP-1 targets expression in HeLa cells in basal conditions and upon sub-lethal hydrogen peroxide treatment.

Authors:  Anna A Belanova; Victor K Chmykhalo; Maxim S Makarenko; Olga V Lyangasova; Maria M Belousova; Anzhela A Aleksandrova; Peter V Zolotukhin
Journal:  Mol Biol Rep       Date:  2018-12-04       Impact factor: 2.316

2.  Low long non-coding RNA HOTAIR expression is associated with down-regulation of Nrf2 in the spermatozoa of patients with asthenozoospermia or oligoasthenozoospermia.

Authors:  Lixin Zhang; Zhineng Liu; Xiaokang Li; Ping Zhang; Jia Wang; Dandan Zhu; Xinping Chen; Lihua Ye
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 3.  Polyphenol Stilbenes: Molecular Mechanisms of Defence against Oxidative Stress and Aging-Related Diseases.

Authors:  Mika Reinisalo; Anna Kårlund; Ali Koskela; Kai Kaarniranta; Reijo O Karjalainen
Journal:  Oxid Med Cell Longev       Date:  2015-06-09       Impact factor: 6.543

4.  Hepatic gene expression profiling in Nrf2 knockout mice after long-term high-fat diet-induced obesity.

Authors:  Dionysios V Chartoumpekis; Panos G Ziros; Apostolos Zaravinos; Ralitsa P Iskrenova; Agathoklis I Psyrogiannis; Venetsana E Kyriazopoulou; Gerasimos P Sykiotis; Ioannis G Habeos
Journal:  Oxid Med Cell Longev       Date:  2013-04-18       Impact factor: 6.543

5.  Curcumin improves asthenozoospermia by inhibiting reactive oxygen species reproduction through nuclear factor erythroid 2-related factor 2 activation.

Authors:  Qiao Zhou; Xun Wu; Yingmin Liu; Xin Wang; Xiufeng Ling; Hongshan Ge; Junqiang Zhang
Journal:  Andrologia       Date:  2019-12-03       Impact factor: 2.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.